Page last updated: 2024-10-16

carnitine and Cytomegalic Inclusion Disease

carnitine has been researched along with Cytomegalic Inclusion Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Adefovir dipivoxil is a novel nucleotide analogue with several promising in vitro anti-human immunodeficiency virus (HIV) characteristics."2.68The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. ( Cherrington, JM; Collier, A; Deeks, SG; Drew, WL; Hellmann, N; Jaffe, HS; Kahn, J; Lalezari, J; Lamy, PD; Li, W; Mulato, AS; Pavia, A; Rodrigue, D; Toole, J, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deeks, SG1
Collier, A1
Lalezari, J1
Pavia, A1
Rodrigue, D1
Drew, WL1
Toole, J1
Jaffe, HS1
Mulato, AS1
Lamy, PD1
Li, W1
Cherrington, JM1
Hellmann, N1
Kahn, J1

Trials

1 trial available for carnitine and Cytomegalic Inclusion Disease

ArticleYear
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.
    The Journal of infectious diseases, 1997, Volume: 176, Issue:6

    Topics: Adenine; Administration, Oral; Adult; Anti-HIV Agents; Carnitine; CD4 Lymphocyte Count; Cytomegalovi

1997